relative to coverage for GLP-1 medication under the state Medicaid plan.
What changed between versions
The bill now directs the Department of Health and Human Services to provide coverage under the state Medicaid plan instead of requiring private health carriers to provide coverage.
Eligibility criteria were expanded to include a BMI of 30 or higher, and a BMI of 27 or higher with specific weight-related comorbidities such as prediabetes and metabolic dysfunction-associated steatotic liver disease.
A new requirement was added for the Department of Health and Human Services to submit necessary amendments to the federal Centers for Medicare and Medicaid Services by January 1, 2027.
The fiscal impact analysis changed from 'indeterminable' to specific estimates, projecting approximately $2 million in state funds and $6.5 million in federal funds for the second half of FY27.